Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Propylparaben. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D known ✓ | Q08499 | 1/20 | 0.53 |
| ▸ | THRB known ✓ | P10828 | 1/20 | 0.49 |
| ▸ | CA12 known ✓ | O43570 | 1/20 | 0.47 |
| ▸ | CA1 known ✓ | P00915 | 1/20 | 0.47 |
| ▸ | CA2 known ✓ | P00918 | 1/20 | 0.47 |
| ▸ | ESR2 known ✓ | Q92731 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.68 |
| ▸ | TSHR | P16473 | 3/20 | 0.68 |
| ▸ | ESR1 | P03372 | 3/20 | 0.68 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.68 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.68 |
| ▸ | KDR | P35968 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 4/20 | 0.65 |
| ▸ | STS | P08842 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylparaben SCHEMBL8361958 | 0.98 | ALDH1A1 (0.66) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| Propylparaben SCHEMBL475797 | 0.96 | ALDH1A1 (0.68) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| Propylparaben SCHEMBL11658475 | 0.95 | ALDH1A1 (0.62) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| Propylparaben SCHEMBL7607113 | 0.93 | ALDH1A1 (0.60) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| Propylparaben SCHEMBL2812584 | 0.90 | ESR1 (0.81) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| Butylparaben SCHEMBL475966 | 0.89 | ESR1 (0.70) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| SCHEMBL49950 | 0.88 | ALDH1A1 (0.84) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| SCHEMBL27647501 | 0.86 | ALDH1A1 (0.81) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| SCHEMBL28758641 | 0.86 | ALDH1A1 (0.81) | ALDH1A1TSHRESR1TDP1CHRM1 | |
| Methane SCHEMBL27699232 | 0.86 | ALDH1A1 (0.81) | ALDH1A1TSHRESR1TDP1CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4052 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120983376-B | Clofazimine soft capsule and preparation method thereof | SHANXI LIYE PHARMACEUTICAL Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | claimed |
| EP-4743053-A1 | ANTIMICROBIAL SYNERGIES | Symrise AG (DE) | 2026-05-20 | — | — | EP | claimed |
| US-12629377-B2 | Lamotrigine oral liquid suspension and use thereof | ROWP IP HOLDING II LLC | 2026-05-19 | — | — | US | claimed |
| US-20260124120-A1 | STABILIZED AQUEOUS COMPOSITIONS CONTAINING HYDROXYAPTITE AND FREE IONS FOR IN VIVO REMINERALIZATION OF CALCIFIED TISSUE & THEIR METHODS OF USE | INTER MED INC (US) | 2026-05-07 | — | — | US | claimed |
| WO-2026090627-A1 | STABLE PITOLISANT LIQUID FORMULATIONS AND METHOD OF ITS USE | PATEL SANDIPKUMAR (US) | 2026-04-30 | — | — | WO | claimed |
| US-12595237-B2 | Lamotrigine hydrate crystal form, preparation method therefor, and composition containing same | SHANGHAI AUCTA PHARMACEUTICALS CO., LTD. (CN) | 2026-04-07 | — | — | US | claimed |
| US-20260069570-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | SLAYBACK PHARMA LLC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4554551-B1 | 3-HYDROXYPROPYLESTERS AS ANTIMICROBIAL AGENTS | SYMRISE AG (DE) | 2026-03-11 | — | — | EP | claimed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | claimed |
| US-12491178-B2 | Stable pharmaceutical compositions of edaravone | SLAYBACK PHARMA LLC (US) | 2025-12-09 | — | — | US | claimed |
| EP-1137671-A1 | REACTION PRODUCTS OF HYALURONIC ACID AND NATURAL AMINO ACIDS AND THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | Jasper Ltd. Liability Co. (US) | 2001-10-04 | — | — | EP | claimed |
| WO-2001064163-A2 | AN IMPROVED HERBAL COMPOSITION HAVING ANTIALLERGIC PROPERTIES AND A PROCESS FOR THE PREPARATION THEREOF | NATURAL REMEDIES PRIVATE LIMITED (IN) | 2001-09-07 | — | — | WO | claimed |
| EP-1121105-A1 | PROPOFOL-BASED ANESTHETIC AND METHOD OF MAKING SAME | Phoenix Scientific, Inc. (US) | 2001-08-08 | — | — | EP | claimed |
| WO-2001032795-A1 | CYANOACRYLATE SOLUTIONS CONTAINING PRESERVATIVES | CLOSURE MEDICAL CORPORATION (US) | 2001-05-10 | — | — | WO | claimed |
| WO-2000071175-A1 | OPHTHALMIC SOLUTIONS INCORPORATING AN ANTIMICROBIAL POLYPEPTIDE | LARGE SCALE BIOLOGY CORPORATION (US) | 2000-11-30 | — | — | WO | claimed |
| WO-2000021517-A1 | PROPOFOL-BASED ANESTHETIC AND METHOD OF MAKING SAME | PHOENIX SCIENTIFIC, INC. (US) | 2000-04-20 | — | — | WO | claimed |
| WO-2000008061-A1 | REACTION PRODUCTS OF HYALURONIC ACID AND NATURAL AMINO ACIDS AND THEIR USE IN COSMETIC AND PHARMACEUTICAL COMPOSITIONS | JASPER LTD. LIABILITY CO. (US) | 2000-02-17 | — | — | WO | claimed |
| EP-0971696-A1 | THIMEROSAL-FREE PRESERVATIVES FOR VACCINES | Merck & Co., Inc. (US) | 2000-01-19 | — | — | EP | claimed |
| WO-1998034594-A1 | THIMEROSAL-FREE PRESERVATIVES FOR VACCINES | MERCK & CO., INC. (US) | 1998-08-13 | — | — | WO | claimed |
| EP-0489217-A1 | Calcitonin compositions for intranasal administration | DR. A. TOSI FARMACEUTICI S.R.L. (IT) | 1992-06-10 | — | — | EP | claimed |